ResearcherRutgers New Jersey Medical SchoolActive in the last 2 years

Daiyong Deng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5899-9177; OpenAlex author ID A5071808079. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer. Co-author DOI 10.1084/jem.20240766 ↗
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance. Co-author DOI 10.3390/cells11192952 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pingping Hou · 2 shared papers, 2022–2024 · strength 0.43
- Paper Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance. DOI 10.3390/cells11192952 ↗
- Paper NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer. DOI 10.1084/jem.20240766 ↗
Habeebunnisa Begum · 1 shared paper, 2024 · strength 0.20
- Paper NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer. DOI 10.1084/jem.20240766 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.